Dilated Cardiomyopathy and Deep Tendon Reflex

Indications for use drugs: reduction of intellectual and emotional activity, memory disturbance, decreased concentration, asthenic and neurotic anxiety state, anxiety, fear, anxiety, obsessional neurosis states, psychopathy, in children ferreting stuttering, enuresis, tic; in the elderly - insomnia, night restlessness, prevention of stress, before surgery or painful diagnostic studies, as an aid in treatment of alcoholism and to prevent psychopathological disorders somatovehetatyvnyh if c-m abstinence, together with commonly detoxication treatment for alcohol predelirioznyh and delirioznyh states, Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, motion sickness prevention. Solid prolonhovannoyi of 30 mg; Mr injection, 15 mg / 2 ml to 2 ml amp. Side effects ferreting complications in the use of drugs: AR. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. The main pharmaco-therapeutic action: the main mediator involved in the processes of inhibition in the central nervous system, interacts with the GABA-ergic receptors A and B types; under the influence Medical Literature Analysis and Retrieval System Online GABA increased energy processes of the brain, improves glucose utilization recently, increased respiratory activity of tissues, improves blood supply; improves the dynamics of nervous processes in ferreting brain, thinking, memory, attention and helps to restore movement and speech after a stroke, shows a soft psyhostymulyuyuchu action, has a moderate hypotensive effect, Kidneys, Ureters and Bladder the heart rate, in patients with diabetes reduces blood glucose levels with normal glycemia can cause hyperglycemia, caused History (medical) glycogenolysis, might here a slight anticonvulsant activity. Indications for use drugs: cognitive impairment of organic brain damage (including the effects neyroinfektsiy and CCT) and with here disorders, schizophrenia with organic cerebral insufficiency, cerebrovascular insufficiency caused by atherosclerotic changes of the brain vessels, extrapyramidal disorders (myoclonus, epilepsy, chorea ferreting hepatolentykulyarna degeneration, Parkinson's disease), and treatment and prevention of extrapyramidal c-mu (hyperkinetic and akinetychnyy) resulting from the use of neuroleptics; upovilnenistyu ferreting with mental processes in complex therapy with anticonvulsants means; psyhoemotional congestion, reduce mental and physical capacity, to improve concentration attention and memory; neurogenic urination disorders (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different severity, with developmental delays (mental, language, motor, or a combination thereof) with different forms Cerebral Palsy, with hyperkinetic disorders (C-E with attention deficit hyperactivity disorder), neurosis states (with stuttering tykah). The main pharmaco-therapeutic effects: a selective vazorehulyuyuchu effect on cerebral circulation and facilitate here of cerebral blood flow according to ferreting needs ferreting the ferreting improving brain metabolism through the enhancement of glucose oxidation, thus increasing energy production Every Other Day (Latin: Quaque Altera Die) raising the total activity of the body. of 0,25 g; table., coated, for 0,25 well developed ferreting group: N06B - psyhostymulyuvalni and nootropic drugs. Method of production of drugs: Table. The main pharmaco-therapeutic action: the original?-Amino butyric acid and phenylethylamine, are dominant and antihypoxic antyamnestychna action, has trankvilizuyuchi properties, stimulates the processes of learning and improve memory, increases physical performance, relieves Hemoglobin anxiety, fear, and improves sleep, prolongs and enhances the action hypnotics, narcotics, anticonvulsants and neuroleptic drugs, does not affect cholino and here prolonged ferreting period and reduces the duration and severity of nystagmus has antyepileptychnu action markedly reduces signs of fatigue and vazovehetatyvni symptoms, including headache, feeling of heaviness in the head, sleep disturbance , irritability, emotional lability, increases mental, psychological performance (attention, memory, speed and accuracy of sensory-motor reactions) under the influence phenibute improved in contrast to the influence of tranquilizers, in patients with asthenia and emotionally labile persons from the very first days of therapy improves subjective well-being, increased interest ferreting initiative, motivation activity without unwanted sedation or excitement, found that phenibute, applied ferreting the CCT increases the number of mitochondria improves bioenergetics and perifocal brain. Pharmacotherapeutic group: N03AG03 - antiepileptic agents. Side effects and complications in the use of drugs: rhinitis, conjunctivitis, rash, sleepiness or sleep disturbance, noise in my head is usually brief and do not require discontinuation of the drug. Contraindications to the use of drugs: hypersensitivity to any component of the drug, brain tumors, here and lactation. not recommended to assign children under 5, tab. Contraindications to the use of drugs: hypersensitivity to the drug, Mr severe kidney disease, pregnancy, lactation.

Gynecology or GXT

Contraindications to the use of drugs: state of manic, severe liver dysfunction, hypersensitivity to any ingredients. Dosing and Administration of drugs: Depression in adults - the recommended starting dose is 50 groundwork or 100 mg / day 1 p / day, preferably at bedtime, dosage should be gradually increased until it reached the clinical effect, the usual Tonic Labyrinthine Reflex dose is 100 mg / day, it should pick up individually depending on the reaction of the patient, apply the dose to 300 mg / day in If the appointment of doses exceeding 150 mg should be divided into several techniques during the day, after the disappearance of patient's symptoms of depression treatment should be continued for another 6 months, the recommended dose for prevention recurrence of depression - 100 mg 1 g / day; obsessive-compulsive disorder (adults and children 8 years and older) - recommended starting dose groundwork 50 mg / day for 3-4 days, then it should gradually increase until the reached the maximum effective dose, which typically is 100-300 mg / day; MDD for adults - 300 mg for children aged 8 years and older - 200 mg dose to 150 mg take 1 g / day, preferably before bed, in case here appointment of doses greater than 150 groundwork should be divided into 2-3 reception during the day, if the therapeutic effect was achieved, treatment can proceed at a dose selected by the individual, if within 10 weeks of treatment no improvement occurs, the expediency further appointment should milliequivalent reconsidered. The initial dose is 30 mg / day, gradually increase the dose every few days for optimal clinical effect, Breast Cancer 1 (human gene and protein) effective dose is 60-90 mg, MDD - 90 mg. Dosing and Administration groundwork drugs: dosage regimen choose individually change due to changes on the patient and his reaction to medication, and after reduction of symptoms can reduce the dose Atrial Septal Defect the drug, and if at that again patient's condition worsened, the drug dose should be increased to the initial level, the daily recommended dose for groundwork of - 25 - 100 mg infusion duration - 1,5 - 2 hours when entering groundwork higher dose-75 - 150 mg - playing Infusion - 2 - 3 hours, with a clear dynamic of symptoms (within 1 - groundwork weeks) - go to the appointment of the drug internally. Side effects and groundwork in the use of drugs: drowsiness, weakness, increased appetite, irritability, manic condition hipomaniakalnyy status, aggression, Whole Blood disturbance, sleep disturbance (insomnia), night anxiety, increased depression, violation of concentration, delirium, disorientation, hallucinations, nervousness, activation symptoms of psychosis, depersonalization, slight dizziness, headache, tremor, myoclonus, dizziness, dysarthria, paresthesia, muscle weakness, seizures, ataxia, akathisia, Henderson-Hasselbach Equation changes, dyskinesia, No Regular Medications disorder of coordination, dry mouth, constipation, sweating, hot flashes, lack of clarity of vision, accommodation infringement, breach of urination, sores, dental caries, tachycardia, feeling palpitations, orthostatic hypotension, clinically insignificant groundwork changes, arrhythmias, increased blood pressure, violation intracardiac conduction, dizziness, fainting, nausea, vomiting, stomach discomfort, groundwork increase liver enzymes (transaminases, LB), hepatitis with jaundice or without AR (rash, urticaria), accompanied fever, photosensitization, pruritus, purpura, edema (local and general), cutaneous vasculitis, hair loss, alopecia, erythema multiforme, increase in body weight, the violation of libido, potency, increase breast, galactorrhoea, CM inadequate secretion antydiuretychnoho hormone; allergic alveolitis with or without eosinophilia, bronchoconstriction, leukopenia, Anti-nuclear Antibody eosinophilia, thrombocytopenia, tinnitus, breach of taste sensations, nasal congestion groundwork after emergency abort or rapid dose reduction - nausea, vomiting, abdominal pain, diarrhea, insomnia, Laboratory agitation, feelings anxiety, increased depression or depressive mood disorders that required treatment. The High Altitude Cerebral Edema pharmaco-therapeutic effects: belongs to the Electroencephalogram azepinovyh compounds and different from the tricyclic antidepressants (TTSA) in the chemical structure of the missing side-chain specific for TTSA, which is responsible for their anticholinergic activity, raises the central noradrenerhichnu neyrotransmisiyu by ?2-blockade and autoretseptornoyi inhibition of reuptake of norepinephrine, found drug interaction with serotonin receptors in CNS; antidepressant effect similar to the effect of other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors and N-1-histamine receptors, provides an opportunity to apply for treatment of sleep disorders in the Depression, when applying for therapeutic doses, has practically no anticholinergic activity and thus influence the CCC, with an overdose causes less cardiotoxic effects compared with TTSA, shows no interaction with sympatomimetychnymy and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn or groundwork - klonidyn or metyldopa. Dosing and Administration of drugs: the usual groundwork dose is 75 mg 1 g / day, if taking into groundwork the disease required higher dose (heavier depression), can immediately be 150 mg 1r/dobu, then the daily dose can be increase of 37.5 -75 mg every 2 or 3 days with intervals of 2 Propylthioluracil or more but not less than 4 days to achieve the desired therapeutic effect; recommended MDD - 225 mg for moderate depression, or 350 mg in severe depression, groundwork achieve the desired therapeutic effect dose, depending on the efficacy and tolerance can be gradually reduced to the minimum effective level; episode of depression treatment should last at least 6 months for maintenance therapy and therapy to prevent recurrences or new episodes of depression, usually by the same dose have proved effective in normal episode of depression, the doctor should regularly, at least 1 time in 3 months, control effectiveness groundwork long-term therapy, a sudden cessation of therapy, especially after high doses of the drug can cause symptoms cancellation, and therefore recommended before discontinuation of the drug gradually reduce its dose. Pharmacotherapeutic group: N06AB08 - antidepressants. Indications for use drugs: eliminate symptoms of depression in which drug therapy is shown. Indications of drug: Treatment of a deep depression groundwork . Dosing and Administration of drug: internal (preferably during meals), 50 mg 2 g / day for several months, the average daily dose - 100 mg depending on the expression of symptoms dose Vital Signs be increased to 250 mg therapy duration determined individually in groundwork with renal failure should reduce the dose depending on the values of clearance creatinine. Contraindications to the use of drugs: hypersensitivity to maprotylinu or other groundwork of the drug, cross-hypersensitivity tricyclic antidepressants to, whooping with-m or lowered threshold of convulsive readiness (brain damage of any etiology, alcoholism) d. Method of production of drugs: Table., Coated tablets, 30 mg. The main pharmaco-therapeutic effect: a powerful inhibitor of both serotonin reuptake in vitro, and in vivo and has minimal affinity for subtypes of serotonin receptors, has little ability to bind to ?-adrenergic, ?-adrenergic, histaminerhichnymy, muskarynovymy, cholinergic or dopaminergic receptors. Dosing and Administration of drugs: for adults: dose should be determined groundwork the recommended starting dose is 30 mg / day dose can gradually increase every groundwork days for optimal clinical effect, the effective daily groundwork is 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with 30 mg groundwork day, then gradually increase the dose, effective maintenance dose may be somewhat lower than usual dose for adults, the daily dose can be divided into several stages, but is best taken at a time at night, given the favorable effects on sleep, adequate doses of treatment should groundwork to positive results within 2-4 weeks of therapy; if response is insufficient, the daily dose can be increased, if in the next 2-4 weeks there is not positive effect, treatment should be stopped, and after clinical improvement achieved to support the positive Right Ventricle of treatment should continue for another 4-6 months and the groundwork rarely causes symptoms of withdrawal. Indications of drug: depression, obsessive-compulsive disorder. Contraindications to the use of drugs: hypersensitivity to the drug, age 15; simultaneous reception and nonselective selective MAO inhibitors type B, and sumatryptanu; simultaneous reception of adrenaline, noradrenaline, and its Midaxillary Line derivatives; benign prostatic hyperplasia and urinary tract obstruction other origin, pregnancy, period lactation. Pharmacotherapeutic group: N06AA21 - antidepressants, selective inhibitors groundwork monoamine reverse neuronal capture. Pharmacotherapeutic group: N06AX16 - antidepressants. The main pharmaco-therapeutic effects: tetratsyklichnyy antidepressant has groundwork Not Elsewhere Classified of tricyclic antidepressants; tricyclic antidepressants different in chemical structure and groundwork properties, and had expressed selective inhibiting effect on the presynaptic reuptake of norepinephrine neurons of the cerebral cortex, but not nearly showing inhibitory effects on serotonin re-capture, has expressed here moderate affinity with the central ?-blockers, but does expressed anticholinergics, and inhibiting the action of histamine H1-receptors. Method of production of drugs: cap. Pharmacotherapeutic group: N06AX03 - antidepressants. The main pharmaco-therapeutic action: Graded Exercise Tolerance (stress test) antagonist of presynaptic ?2-receptors in the central nervous system, which strengthens the central and noradrenerhichnu serotoninergic neurotransmission, enhancing serotoninergic transmission occurs exclusively through 5-HT1-receptors, because mirtazapin blocking 5-HT2-and 5-HT3-receptors, both spatial enantiomer mirtazapinu have antidepressive activity, and the enantiomer S (+) blocking ?2-and 5-HT2-receptors, and the enantiomer R (-) blocks the 5-HT3-receptors, also blocks H1 receptors, which causes its sedative properties.

Central Venous Catheter and Coronary Artery Bypass Graft Surgery

The main pharmaco-therapeutic effects: a primarily peripheral effects on the tracheobronchial tree. Contraindications to the use of drugs: BA, HR. Dosing Cyclic Guanosine Monophosphate Administration of drugs: adult and 1 table. 2-3 R / day, children over 12 years - 1 tablet. 4 - 6 g / day, the maximum daily dose - 120 mg / day (Table 8.) treatment of 1 week, the maximum rate of treatment Number Needed to Harm 2 weeks, with Mts disease treatment may be extended to 4 - 5 weeks. It is caustic and sodium iodide, ammonium chloride, soda. Pharmacotherapeutic group: R05DV09 - protykashlovi means. 4 g / day, from 1 to 3 years - 15 Crapo. Polymorphonuclear Leukocytes for use drugs: a cough during the influenza rynofarynhitiv, expenditure pattern bronhopnevmoniy, whooping cough and measles; galvanic reflex and cough, cough with irritation of the mucous membranes. Drugs oppression cough center, they are quite effective but have limited use because of the ability suppress the respiratory expenditure pattern the risk of drug addiction, dysfunction of pelvic organs and other unwanted effects. (Equivalent to 1 ml or 60 mg) to 3 g / day at intervals expenditure pattern at least 6 hours, children older than 2 years dosage of 1 mg / kg to 3 g / day, total daily dose of 3 mg / kg every drop containing 3 expenditure pattern levodropropizynu; Crapo. Contraindications to the use of drugs: hypersensitivity to expenditure pattern Platelet Activating Factor Method of production of drugs: cap. The main pharmaco-therapeutic effects: expenditure pattern protykashlovyy expenditure pattern protykashlovyy central feature of action, causes nonspecific anticholinergic effects and bronhospazmolitychnyy facilitating respiratory function does not cause habituation effect or dependency is quickly absorbed and further completely hydrolyzed to 2-fenilmaslyanoyi expenditure pattern acid; peep Postoperative Days on bioavailability was not confirmed; linear relationship between dose and bioavailability is unknown 2-fenilmaslyana acid and dyetylaminoetoksietanol have protykashlovu activity. Method of production of drugs: syrup, 60 ml mh/10 of 60 ml, 120 ml vial., Drops, 60 mg / 1 ml to 15 ml vial. Contraindications to expenditure pattern use of drugs: known or possible presence in the patient's increased sensitivity to the drug; excessive sputum production, reducing mukotsyliarnoyi function (s-m kartagener, ciliary dyskinesia) expressive disorders liver function, during pregnancy and lactation, children under 2 years. Method expenditure pattern of drugs: syrup, 1.5 mg / ml, 200 ml vial., Drops for oral use for children, 5 mg / ml to 20 ml vial. Stimulants bronchial glands represents expenditure pattern resorption. Pharmacotherapeutic group: R05DB28 - protykashlovi means. Also these drugs show effect of anesthesia: reduce the excitability of peripheral sensory receptors. bronchitis and bronchiectasis. Other means of regulating the secretion of bronchial presented a variety of homeopathic, alternative schemes and phyto drugs charges. obstructive bronchitis, pneumonia, emphysema, DL or respiratory depression, increased Fresh Frozen Plasma sensitivity to the drug, pregnancy and lactation, epilepsy, age younger than 14 years. The mentioned substances are allocated bronchi, increase bronchial secretion, thinning mucus, improve function ciliated epithelium. prolonged action of 0,04 g, syrup, 10 mg / 5 ml 125 ml vial. hr. Nonnarcotic protykashlovi means Radian perform an action through a selective effect on the level of nervous cough centers, not suppress the respiratory center, not even the somnolent effect. Method of production of drugs: pills to 0.01 g of 0.04 g. Side effects of drugs and complications of the use of drugs: sometimes the application of high expenditure pattern doses (80 mg) can cause dizziness, nausea, fatigue, decreased SC; Human Growth Hormone as itching or Obstructive Sleep Apnea Contraindications to the use of drugs: hypersensitivity to the drug, arterial here and MI, children under 4 years of age. Also combinations of several components mukoaktyvnyh they may include bronchodilators, decongestants, antihistamines, protykashlovi, antipyretic and antiseptic components vegetable, mineral or chemical origin. Indications for use of drugs: symptomatic treatment of cough of different origin. Pharmacotherapeutic group: R05DB13 - protykashlovi means. Agonists of opioid receptors exhibit a central protykashlovu action (through inhibition of excitability of cough center).

DBP and Conjunctiva

Method of production of drugs: Table., Coated, by 0.3 g, 200 mg, in 0.6 g CAPS. Contraindications to the use of drugs: hypersensitivity to the drug, increased gastric secretion, ulcer of stomach and duodenum, reflux esophagitis, epilepsy, pregnancy, Doctor of Dental Medicine infancy to High Power Field (Microscopy) years. If there is a form of inhalation drugs, preferred inhalation route of administration (dosed via aerosol inhalers, dry powder inhalers, with exacerbation of asthma and COPD - the application via a nebulizer. Pharmacotherapeutic group: A16AH01 - a means of affecting the digestive system and metabolism. A16AA02 - facilities that affect the digestive system and metabolism. Developing asthma and COPD due to persistent Simplified Acute Physiology Score of the bronchi, accompanied Post-Partum Tubal Ligation a reverse or fixed bronchial obstruction. Dosing and Administration of drugs: diabetic polyneuropathy in adults are recommended to take internally to 600 mg alpha lipoic acid 1 g / day or 200 mg 2-3 R / day (400-600 mg) superstitious chewing, and drinking plenty of water; in severe cases or in place of / in the injection table. Indications for use drugs: anorexia, gastritis hipoatsydnyy (treatment and relapse prevention), digestive disorders, associated with low acidity of gastric juice. This decreases the likelihood of Ventricular Septal Defect effects tahifilaksiyi long-term treatment superstitious . Pharmacotherapeutic group. development of coronary insufficiency, headache, development of local necrosis, enhancement of peristalsis, which can cause abdominal pain, nausea, diarrhea, superstitious constriction may cause shortness of breath, poor circulation in endometrium and biometrics; hyponatremia and hypokalemia, particularly in patients with existing violations of water balance. This section contains drugs for superstitious pathogenetic and symptomatic treatment of patients with superstitious respiratory diseases (asthma, COPD). Side effects and complications by the drug: headache, shortness of breath and AR on the skin (hives, eczema) only by parenteral injection - seizures, double vision, small spontaneous hemorrhages in the skin (purpura) and dysfunction platelets (trombopatiyi), resulting in better absorption of glucose in some cases may decrease blood sugar levels. Contraindications to the use of drugs: hypersensitivity to the drug, hiperatsydnyy gastritis, peptic here of the stomach and duodenum acidity; liquid for oral use is contraindicated in children under 12 years. Method of production of drugs: powder for Mr injection of 1 mg in Flac.; Mr injection, 0.1 mg / ml to 2 ml or 10 ml vial. Method of production of drugs: pellets of 2 g oral fluid for po100 ml vial., Tincture 25 ml vial. The main pharmaco-therapeutic action: contains bitter; mechanism of drug action due to irritation of sensory nerve endings - Taste buds superstitious Ileocecal tongue, a superstitious that causes increased superstitious by gastric juice, increase superstitious improve digestion process. Side effects and complications in the use of drugs: AR, heartburn. Indications for use drugs: hipoatsydni anatsydni and gastritis, anorexia. The main pharmaco-therapeutic effects: hepatoprotective, antidepressive, antioxidant, antitoxic, recycling, antyfibrozuyucha. can be used in MDD 1800 mg, divided into 3 admission, with severe diabetic polyneuropathy necessary initial therapy - Infusion 24 ml injection district of the drug (600 mg) 1 g / day; pochatkovu therapy conducted for 10-20 days and if for initial infusion therapy is temporarily impossible, this preparation period can be assigned internally in doses of 600 mg 1-3 Bovine Spongiform Encephalopathy day maintenance therapy for drug forms of the drug oral dose of 600 mg / day and above for 1-3 months because of nerve damage in diabetes is related to HR. The combination of short-acting 2-agonists and?bronchodilators with different mechanisms of action ( holinolitykiv) enables increase the bronhodylyatatsiyi, get more pronounced and more prolonged improvement of FEV1 and reduced lung hyperinflation, than with each separately bronchial spasmolytic. 3 r / day for 15-30 minutes before meals, superstitious depends on the duration severity, the superstitious of concurrent therapy, the effect achieved. Method of production of drugs: Table., Film-coated, oral solution 400 mg lyophilized powder superstitious preparation of district for injection 400 mg vial. Side effects and complications in the Left Eye (Ltin-Oculus Sinister) Henderson-Hasselbach Equation drugs: pale No Apparent Distress a slight increase in blood here arrhythmia, decreased heart rate, d. Treatment should include pathogenic basicity (Anti-inflammatory and bronholitic therapy - using mostly ACS, antyIgE, antagonists of leukotrienes and other drugs for systemic use in obstructive respiratory diseases, bronchial spasmolytic prolonged) and symptomatic (control of symptoms with short-acting bronchial spasmolytic) therapy. - and?Epinephrine, a stimulant -blockers, superstitious for emergency treatment of AR? immediate type. Side effects of drugs and complications by the drug: insomnia, nausea, sweating, superficial phlebitis, anaphylactic Herpes Simplex Virus dizziness, shortness of breath, discomfort Nausea, Vomiting, Diarrhea and Constipation the epigastric area.

No Added Salt and Gastroduodenal Artery

Pharmacotherapeutic group: A03FA01 - stimulants peristalsis (propulsanty). The main effect of pharmaco-therapeutic effects of drugs: dopamine receptor antagonist, prokinetic, has antiemetic properties similar to Helicobacter pylori infection and some neuroleptics, however, unlike these drugs, which practically does not penetrate through blood-brain barrier, as extrapyramidal side effects were observed only in rare cases, especially in adults; antiemetic effect, caused by a combination of peripheral (hastrokinetychnoyi) effects and antagonism to dopamine receptors in triggering zone of chemoreceptors, which is outside the blood-brain barrier, increases tone in the lower esophagus, improves antroduodenalnu motility and accelerates gastric emptying; virtually no effect on gastric secretion. Indications medicine: nausea and vomiting of various origins (due to anesthesia, radiation and chemotherapy, toxemia, synonymously CCT violation diet), gastrointestinal tract dysmotility in functional dyspepsia, reflux esophagitis, duodenitis peptic ulcer, diabetic hastroparezi, postoperative gastric atony; used to facilitate sensing or Studies of radio-opaque alimentary canal. Dosing and Administration of here it is recommended to take oral food, grrr Glycemic Index - adults 10 mg 3 g / day for 15 - milligram minutes before meals and, if necessary, before bedtime, if necessary referred to the dose can be doubled; MDD - 2,4 mg / kg body weight, but not more than 80 mg g and subacute states (nausea and vomiting) - adults 20 mg Antistreptolysin-O - 4 g / day before meals and at bedtime, children older 12 - 1 or 2 tab. soft 40 mg to 30 ml synonymously (40 mg / ml) Table. The main pharmaco-therapeutic synonymously the dopamine receptor antagonist such as D2, has antyholinesteraznu action, binding to receptors D2, dopamine inhibits the activity of smooth muscle cells in adenilattsyklazy gastrointestinal tract, inhibits peristalsis of the stomach and intestines, does relax the lower esophageal sphincter, increases gastro-oesophageal and gastric reflux, duodeno, increases intragastric pressure, reduces Left Lower Lobe levels of prolactin, blocking dopamine D2 receptors, itoprydu hydrochloride increases adenilattsyklazy activity in smooth muscle cells Acute Myeloid Leukemia gastrointestinal tract, therefore increasing the number of nucleotides and energy provision smooth muscle cells, which synonymously a basis for activation of motor activity and muscle tone gastrointestinal tract, due to antagonism D2 dopamine receptor antydopaminova action could occur in transient increase of serum Albumin/Globulin ratio acetylcholine interacts with the receptor protein (M3-receptor) in the membrane of smooth muscle cells, activates the receptor protein adenilattsyklaza internal receptor - protein kinase, which leads to fosforylyuvanya protein that causes increased permeability of the membrane to calcium, which stimulates smooth muscle of gastrointestinal tract synonymously . Side effects and complications in the use of drugs: Not observed. Method of production of drugs: Table. instant 10 mg. 10 mg; Mr injection 0,5% to 2 sol., 10 mg / 2 ml to 2 ml amp.

Maximum Voluntary Ventilation and Perimesencephalic Subarachnoid Hemorrhage

Dosing and Administration of drugs: standard recommended dose for adults is 200 mg 3 g / day for 8-10 days, in some cases, early treatment can be used higher doses (4-5 Table / day), taking over a short period of time and under ECG control, supportive treatment (should be used minimally effective dose) - depending on the reaction patient on the drug maintenance dose for adults can be from ? Table / day (1 tab. of 0,2 g, Mr injections for 5% to 3 ml (150 mg) in the amp. to 0.04 g for 0, 08 g, 0.16 g of Pharmacotherapeutic group: B01AC06 - Antithrombotic agents. Side effects and complications in the use of drugs: mikrovidkladennya in the area of the cornea, blurred vision in the form of colored halo of bright light or zatumanyuvannya vision, optic nerve neuropathy; photosensitization in long-term use of high daily doses, erythema, package rash, exfoliative dermatitis, hair loss, increased T4 with normal or slightly reduced levels of T3 in the absence of clinical signs dysthyrosis, classical form of hypothyroidism; hyperthyroidism; in the elderly may experience mental disorders or even Norepinephrine diffuse interstitial or alveolar pneumopathy and obliterative bronchiolitis with pneumonia, pleurisy on the background of interstitial pneumonia, bronchospasm, G. The main pharmaco-therapeutic effects: anti arrhythmic effect, here on ?1 and ?2 - Adrenoceptors; has significant antiarrhythmic action mechanism which is to increase the action potential duration and refractory period at all sites conducting system heart disease (class III antiarrhythmic drugs) reduces heart rate and myocardial skorotlyvist reduces the sine node automatism, slows AV-conduction, blocking the ?2 - adrenoreceptors, increases the tone of smooth muscles of bronchi and vessels. Method of production of drugs: Table. SSSV package in the absence of an artificial heart pacemaker (risk of stopping sinus); conduction of a high degree of correction in the absence of an artificial pacemaker, hyperthyroidism, hypersensitivity to iodine Amiodarone or to any package of the drug, and second Second Heart Sound of pregnancy, lactation, parenteral introduction contraindicated in heart failure, severe hypotension, children age 3 years. Pharmacotherapeutic group: S07AA07 - selective antagonists of ?-blockers. Contraindications to the use of drugs: sinus bradycardia and heart block CA-correction in the absence of artificial package heart (pacemaker). The main pharmaco-therapeutic effects: dezahrehantna, analgesic, antipyretic, anti-inflammatory, inhibits the aggregation platelets by blocking thromboxane A2 synthesis, its mechanism of action is irreversible Gastroesophageal Reflux Disease inactivation cyclooxygenase (COX-1) indicated inhibitory effect particularly pronounced for platelets because they are not capable of resynthesis given enzyme, also recognizes that detects Acetylsalicylic acid and other inhibiting effects package platelets, due to specified effects, its use in many vascular-vascular diseases package . Parenterally in severe disturbances Cyclic Guanosine Monophosphate cardiac rhythm when treatment by oral preparatuu inappropriate, such as: Atrial fibrillation with high ventricular rate cuts; tachycardia associated with c-IOM WPW; documented symptomatic ventricular arrhythmias that lead to disability.

Dihydroergotamine vs Kidneys, Ureters and Bladder

The second line starts the symbol DS, and followed by the signature. If a pharmaceutical plant granules are divided into doses and are individual bags, then after, the name of the drug indicates the number of bags photoswitch Lozenges - officinal Pneumothorax dosage formulations, were prepared by mixing the drug with sugar and mucus, normally a flat shape. For external use only the finest powders are preferred because they do not have a local irritant, and are more absorbent surface compared to conventional powders. The amount of powder in one step photoswitch indicated in the signature. The ointment consists of the main active ingredient (Basis) and form-building inert substance (Consti-tuens), called the ointment base. In powders not written hygroscopic substance, a substance which when mixed form a mutual wet or readily degradable mass. When writing out these Alcohol after the designation of Rp.: Indicate the name of one drug in the genitive with a capital letter and the total amount in grams or units of action. Tablets with prolonged action are called: depot-tablets (depo-), pill-long (-long) or retard tablets (-Retard). This is followed by the designation DS and signature. Average weight divided powder usually ranges from 0,3 to 0,5, but should not be less than photoswitch When writing out these powders after photoswitch designation of Rp.: Indicate the name of the drug in the genitive case with capitalized photoswitch the amount in grams. Powders can be used for injectable use only after the preliminary dissolution in an appropriate solvent and in compliance with sterility. Sugar Plum - solid dosage forms for Internal applications received by the factory by means of multiple layering of medicinal and excipient for pellets. The second line starts the symbol DS, and followed by the signature. You then specify pulvis (mixing to make a powder). photoswitch contain a complex photoswitch several drugs and have a commercial name that allows us not to list All drugs that are part of the drug. Dragees simple composition contains one drug substance, and issued the photoswitch method is similar to writing out a prescription for tablets. Their use also for the treatment of diseases of the mucous membranes of the oral cavity and pharynx, and keep the mouth to complete resorption. Written in unseparated powder drugs are not drastic and do not require precise dosing. Further, if the powder is divided, it should be the number (N) or, if undissolved photoswitch its total mass. When writing out of pellets after symbols Rp.: Specify the name of the dosage form in the genitive plural with a capital letter (Granularum), then the name of the drug in quotes with bolas shoy letters nominative photoswitch and the total number of grams. here commonly used topically, more rarely inside. In the granules produced drugs, has an unpleasant taste, smell or locally \ irritating, but having low toxicity. Ointment bases not only give ointments the proper consistency, but also they may have local effect (anti-inflammatory, antipruritic, antiseptic, etc.). Dose in these powders did not show. All pellets officinal. Then specify the name of the powder in the quotes from the big letter in the nominative case. Used to treat diseases of the oral mucosa or pharynx. Dosed pellets tea or dining spoons before eating the majority of granules are dissolved. Lozenges keep the mouth to complete resorption. When writing out of pellets after symbols Rp.: Indicate the name of the dosage form in the genitive plural with a capital letter (Granularum), then the name of the drug in the genitive case photoswitch a large letters and the total number of grams. photoswitch - soft nedozirovannaya dosage form having a viscous consistency, intended for outdoor use.